溫通針法治療寒凝血瘀型原發(fā)性痛經(jīng)隨機(jī)對(duì)照研究

孫潤(rùn)潔 田亮 朱博雯 秦曉光

摘要：目的 觀察溫通針法治療寒凝血瘀型原發(fā)性痛經(jīng)的臨床療效。方法 將120例寒凝血瘀型原發(fā)性痛經(jīng)患者隨機(jī)分為溫通針法組和對(duì)照組各60例。溫通針法組取關(guān)元、三陰交、十七椎、地機(jī)施以溫通針法，次髎、合谷、太沖運(yùn)用平補(bǔ)平瀉法；對(duì)照組選穴同溫通針法組，運(yùn)用平補(bǔ)平瀉法。2組均于月經(jīng)來潮前5～7 d開始治療，每日1次，連續(xù)7次，療程均為3個(gè)月經(jīng)周期。采用視覺模擬評(píng)分法（VAS）和COX痛經(jīng)癥狀量表（CMSS）評(píng)價(jià)治療第1、2、3個(gè)月經(jīng)周期末的疼痛程度，治療結(jié)束后3個(gè)月隨訪評(píng)價(jià)臨床療效。結(jié)果 2組患者治療后VAS和CMSS評(píng)分較治療前明顯下降（P<0.01），溫通針法組VAS和CMSS評(píng)分明顯低于同周期對(duì)照組（P<0.05）。溫通針法組總有效率為96.67%（58/60），對(duì)照組為73.33%（44/60），差異有統(tǒng)計(jì)學(xué)意義（P<0.05）。結(jié)論 溫通針法治療寒凝血瘀型原發(fā)性痛經(jīng)患者，能明顯緩解痛經(jīng)癥狀、縮短疼痛時(shí)間，具有肯定的臨床療效。

關(guān)鍵詞：原發(fā)性痛經(jīng)；寒凝血瘀；溫通針法；視覺模擬評(píng)分法；COX痛經(jīng)癥狀量表；隨機(jī)對(duì)照試驗(yàn)

DOI：10.3969/j.issn.1005-5304.2016.01.005

中圖分類號(hào)：R271.915 文獻(xiàn)標(biāo)識(shí)碼：A 文章編號(hào)：1005-5304（2016）01-0023-04

Randomized Controlled Study on Warm-promotion Needling for Treatment of Cold Coagulation and Blood Stasis of Primary Dysmenorrhea SUN Run-jie， TIAN Liang， ZHU Bo-wen， QIN Xiao-guang （Gansu University of Chinese Medicine， Lanzhou 730000， China）

Abstract： Objective To observe clinical efficacy of warm-promotion needling for the treatment of cold coagulation and blood stasis of primary dysmenorrhea. Methods Totally 120 patients with cold coagulation and blood stasis of primary dysmenorrhea were randomly divided into warm-promotion needling group （60 cases） and control group （60 cases）. Warm-promotion needling group was treated with warm-promotion needling at Guanyuan （RN4）， Sanyinjiao （SP6）， Shiqizhui （EX-B8）， and Diji （SP8）， and cooperated with Ciliao （BL32）， Hegu （LI4）， and Taichong （LR3）. Control group took same acupoints and applied uniform reforcing-reducing method. The two groups began treatment 5-7 d before menstruation， 1 times a day， for 7 times. The treatment was given 3 menstrual cycles. The visual analogue scale （VAS） and COX menstrual symptom scale （CMSS） were used to observe the pain degree at the end of 1， 2， 3 menstrual cycles. The clinical efficacy was evaluated 3 months after treatment. Results The scores of VAS and CMSS was obviously reduced in the two groups after the treatment compared with those before treatment （P<0.01）. The synperiodic scores of VAS and CMSS in warm-promotion needling group was obviously lower than those in the control group （P<0.05）. The total effective rate of warm-promotion needling group was 96.67% （58/60）， and the control group was 73.33% （44/60）， the difference was significant （P<0.05）. Conclusion Warm- promotion needling can obviously relieve dysmenorrhea symptoms and shorten the time of pain of patients with cold coagulation and blood stasis of primary dysmenorrhea， which has affirmative clinical efficacy.

Key words： primary dysmenorrhea； cold coagulation and blood stasis； warm-promotion needling； visual analogue scale； COX menstrual symptom scale； clinical efficacy； randomized controlled trial